Wright Investors Service Inc Regeneron Pharmaceuticals, Inc. Transaction History

Wright Investors Service Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$595.12 - $698.43 $2.09 Million - $2.45 Million	-3,515 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$543.48 - $670.97 $59,782 - $73,806	110 Added 3.23%	3,515 $2.22 Million
Q3 2021 Nov 01, 2021	BUY	$574.03 - $680.96 $1.95 Million - $2.32 Million	3,405 New	3,405 $2.06 Million
Q1 2021 Apr 29, 2021	SELL	$446.73 - $548.2 $337,281 - $413,891	-755 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$478.3 - $607.98 $361,116 - $459,024	755 New	755 $365,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Wright Investors Service Inc, based on Form 13F filings with the SEC.

Stay updated on Wright Investors Service Inc with notifications on news.